Disruption of the HIF-1 pathway in individuals with Ollier disease and Maffucci syndrome

被引:10
|
作者
Poll, Sarah R. [1 ]
Martin, Renan [1 ]
Wohler, Elizabeth [1 ]
Partan, Elizabeth S. [1 ]
Walek, Elizabeth [1 ]
Salman, Shaima [1 ]
Groepper, Daniel [2 ]
Kratz, Lisa [1 ]
Cernach, Mirlene [3 ]
Jesus-Garcia, Reynaldo [4 ]
Haldeman-Englert, Chad [5 ]
Choi, Yoon Jae [6 ]
Morris, Carol D. [7 ,8 ]
Cohen, Bernard [9 ]
Hoover-Fong, Julie [1 ]
Valle, David [1 ]
Semenza, Gregg L. [1 ]
Sobreira, Nara L. M. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Dept Genet Med, Baltimore, MD 21218 USA
[2] Southern Illinois Univ, Sch Med, Dept Pediat, Springfield, IL USA
[3] Univ Metropolitana Santos, Santos, SP, Brazil
[4] Univ Fed Sao Paulo, Dept Orthoped Oncol, Sao Paulo, Brazil
[5] Mission Fullerton Genet Ctr, Asheville, NC USA
[6] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA
[7] Johns Hopkins Sch Med, Dept Orthoped Surg, Baltimore, MD USA
[8] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA
[9] Johns Hopkins Sch Med, Dept Dermatol, Baltimore, MD USA
来源
PLOS GENETICS | 2022年 / 18卷 / 12期
关键词
IDH2; MUTATIONS; BINDING SITES; HYPOXIA; HIF-1-ALPHA; HIF-2-ALPHA; REGULATOR; FRAMEWORK; GENES; TUMOR;
D O I
10.1371/journal.pgen.1010504
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Ollier disease (OD) and Maffucci Syndrome (MS) are rare disorders characterized by multiple enchondromas, commonly causing bone deformities, limb length discrepancies, and pathological fractures. MS is distinguished from OD by the development of vascular anomalies. Both disorders are cancer predisposition syndromes with malignancies developing in similar to 50% of the individuals with OD or MS. Somatic gain-of-function variants in IDH1 and IDH2 have been described in the enchondromas, vascular anomalies and chondrosarcomas of approximately 80% of the individuals with OD and MS. To date, however, no investigation of germline causative variants for these diseases has been comprehensively performed. To search for germline causative variants, we performed whole exome sequencing or whole genome sequencing of blood or saliva DNA in 94 unrelated probands (68 trios). We found that 7 had rare germline missense variants in HIF1A, 6 had rare germline missense variants in VHL, and 3 had IDH1 variants including 2 with mosaic IDH1-p.Arg132His variant. A burden analysis using 94 probands assigned as cases and 2,054 unrelated individuals presenting no OD- or MS-related features as controls, found that variants in HIF1A, VHL, and IDH1 were all significantly enriched in cases compared to controls. To further investigate the role of HIF-1 pathway in the pathogenesis of OD and MS, we performed RNA sequencing of fibroblasts from 4 probands with OD or MS at normoxia and at hypoxia. When cultured in hypoxic conditions, both proband and control cells showed altered expression of a subset of HIF-1 regulated genes. However, the set of differentially expressed genes in proband fibroblasts included a significantly reduced number of HIF-1 regulated genes compared to controls. Our findings suggest that germline or early post-zygotic variants identified in HIF1A, VHL, and IDH1 in probands with OD and MS underlie the development of the phenotypic abnormalities in a subset of individuals with OD and MS, but extensive functional studies are needed to further confirm it. Author summary Ollier disease (OD) and Maffucci Syndrome (MS) are rare disorders characterized by multiple enchondromas, commonly causing bone deformities, limb length discrepancies, and pathological fractures. MS is distinguished from OD by the development of vascular anomalies. Both disorders are cancer predisposition syndromes with malignancies developing in similar to 50% of the individuals with OD or MS. Somatic gain-of-function variants in IDH1 and IDH2 have been described in the enchondromas, vascular anomalies and chondrosarcomas of approximately 80% of the individuals with OD and MS. To date, however, no investigation of germline causative variants for these diseases has been comprehensively performed. To search for germline causative variants, we performed whole exome sequencing or whole genome sequencing of blood or saliva DNA in 94 unrelated probands. We found that rare germline missense variants in HIF1A, VHL, IDH1. Our burden analysis found that variants in HIF1A, VHL, and IDH1 were all significantly enriched in cases compared to controls. Our findings suggest that germline or early post-zygotic variants identified in HIF1A, VHL, and IDH1 in probands with OD and MS underlie the development of the phenotypic abnormalities in a subset of individuals with OD and MS, but extensive functional studies are needed to further confirm it.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Regulation of the VHL/HIF-1 Pathway by DJ-1
    Parsanejad, Mohammad
    Zhang, Yi
    Qu, Dianbo
    Irrcher, Isabella
    Rousseaux, Maxime W. C.
    Aleyasin, Hossein
    Kamkar, Fatemeh
    Callaghan, Steve
    Slack, Ruth S.
    Mak, Tak W.
    Lee, Stephen
    Figeys, Daniel
    Park, David S.
    JOURNAL OF NEUROSCIENCE, 2014, 34 (23): : 8043 - 8050
  • [22] Influence of metformin on HIF-1 pathway in multiple myeloma
    Kinga A. Kocemba-Pilarczyk
    Sonia Trojan
    Barbara Ostrowska
    Małgorzata Lasota
    Paulina Dudzik
    Dorota Kusior
    Marta Kot
    Pharmacological Reports, 2020, 72 : 1407 - 1417
  • [23] Influence of metformin on HIF-1 pathway in multiple myeloma
    Kocemba-Pilarczyk, Kinga A.
    Trojan, Sonia
    Ostrowska, Barbara
    Lasota, Malgorzata
    Dudzik, Paulina
    Kusior, Dorota
    Kot, Marta
    PHARMACOLOGICAL REPORTS, 2020, 72 (05) : 1407 - 1417
  • [24] Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome
    Twinkal C Pansuriya
    Ronald van Eijk
    Pio d'Adamo
    Maayke A J H van Ruler
    Marieke L Kuijjer
    Jan Oosting
    Anne-Marie Cleton-Jansen
    Jolieke G van Oosterwijk
    Sofie L J Verbeke
    Daniëlle Meijer
    Tom van Wezel
    Karolin H Nord
    Luca Sangiorgi
    Berkin Toker
    Bernadette Liegl-Atzwanger
    Mikel San-Julian
    Raf Sciot
    Nisha Limaye
    Lars-Gunnar Kindblom
    Soeren Daugaard
    Catherine Godfraind
    Laurence M Boon
    Miikka Vikkula
    Kyle C Kurek
    Karoly Szuhai
    Pim J French
    Judith V M G Bovée
    Nature Genetics, 2011, 43 : 1256 - 1261
  • [25] Multiomics and Systematic Analyses Reveal the Roles of Hemoglobin and the HIF-1 Pathway in Polycystic Ovary Syndrome
    Wang, Guiquan
    Mao, Weian
    Zhang, Yurong
    Yang, Haiyan
    Zhu, Ming
    Li, Yan
    Chen, Wei
    Chen, Yi
    Lou, Chen
    Li, Ping
    Chang, Hsun-Ming
    Yuan, Shuai
    Zhao, Yue
    Mu, Liangshan
    ADVANCED SCIENCE, 2025,
  • [26] Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome
    Pansuriya, Twinkal C.
    van Eijk, Ronald
    d'Adamo, Pio
    van Ruler, Maayke A. J. H.
    Kuijjer, Marieke L.
    Oosting, Jan
    Cleton-Jansen, Anne-Marie
    van Oosterwijk, Jolieke G.
    Verbeke, Sofie L. J.
    Meijer, Danielle
    van Wezel, Tom
    Nord, Karolin H.
    Sangiorgi, Luca
    Toker, Berkin
    Liegl-Atzwanger, Bernadette
    San-Julian, Mikel
    Sciot, Raf
    Limaye, Nisha
    Kindblom, Lars-Gunnar
    Daugaard, Soeren
    Godfraind, Catherine
    Boon, Laurence M.
    Vikkula, Miikka
    Kurek, Kyle C.
    Szuhai, Karoly
    French, Pim J.
    Bovee, Judith V. M. G.
    NATURE GENETICS, 2011, 43 (12) : 1256 - U124
  • [27] Incidence, Predictive Factors, and Prognosis of Chondrosarcoma in Patients with Ollier Disease and Maffucci Syndrome: An International Multicenter Study of 161 Patients
    Verdegaal, Suzan H. M.
    Bovee, Judith V. M. G.
    Pansuriya, Twinkal C.
    Grimer, Robert J.
    Ozger, Harzem
    Jutte, Paul C.
    San Julian, Mikel
    Biau, David J.
    van der Geest, Ingrid C. M.
    Leithner, Andreas
    Streitbuerger, Arne
    Klenke, Frank M.
    Gouin, Francois G.
    Campanacci, Domenico A.
    Marec-Berard, Perrine
    Hogendoorn, Pancras C. W.
    Brand, Ronald
    Taminiau, Antonie H. M.
    ONCOLOGIST, 2011, 16 (12): : 1771 - 1779
  • [28] Restricted Activation of the NF-κB Pathway in Individuals with Latent Tuberculosis Infection after HIF-1α Blockade
    de Oliveira Rezende, Aline
    Saboia, Rafaella Santos
    da Costa, Adeliane Castro
    da Silva Monteiro, Diana Messala Pinheiro
    Zagmignan, Adrielle
    Santiago, Luis Angelo Macedo
    Carvalho, Rafael Cardoso
    Pereira, Paulo Vitor Soeiro
    Junqueira-Kipnis, Ana Paula
    de Sousa, Eduardo Martins
    BIOMEDICINES, 2022, 10 (04)
  • [29] A potential role for mERIC-1 in the HIF-1 pathway.
    Morgan, NA
    Stewart, JP
    Mullan, RN
    Lappin, TR
    Maxwell, AP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 101A - 101A
  • [30] HIF-1α pathway: role, regulation and intervention for cancer therapy
    Georgina N.Masoud
    Wei Li
    ActaPharmaceuticaSinicaB, 2015, 5 (05) : 378 - 389